Expression of vimentin and high-molecular-weight cytokeratin (clone 34ßE12) in differentiating reactive renal tubular cells from low-grade urothelial carcinoma cells in voided urine

Cytopathology

Volumn 22, Issue 4, 2011, Pages 247-252

  Ohsaki, H ^a   Hirakawa, E ^b   Nakamura, M ^c   Norimatsu, Y ^a   Kiyomoto, H ^d   Haba, R ^e  

^a EHIME PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c National Hospital Organization Zentsuji Hospital   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e KAGAWA UNIVERSITY   (Japan)

Author keywords

34 E12; High molecular weight cytokeratin; Immunocytochemistry; Low grade urothelial carcinoma; Reactive renal tubular cells; Urine cytology; Vimentin

Indexed keywords

CYTOKERATIN; VIMENTIN;

AMYLOIDOSIS; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MICTURITION; NEPHROSCLEROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

CARCINOMA; CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATINS; KIDNEY NEOPLASMS; KIDNEY TUBULES; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM; VIMENTIN;

EID: 79960504784     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2010.00791.x     Document Type: Article

References (22)

1. Nguyen GK, Smith R. Repair renal tubular cells: a potential false-positive diagnosis in urine cytology. Diagn Cytopathol 2005;31:342-6.
2. Khalil M, Shin HJ, Tan A et al. Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy. A case report. Acta Cytol 2000;44:86-90.
3. Ohsaki H, Haba R, Matsunaga T et al. Cytomorphologic and immunocytochemical characteristics of reactive renal tubular cells in renal glomerular disease. Acta Cytol 2008;52:297-303.
4. Taft PD, Flax MH. Urinary cytology in renal transplantation: association of renal tubular cells and graft rejection. Transplantation 1966;4:194-204.
5. Ohsaki H, Hirakawa E, Kushida Y et al. Can cytologic features differentiate between reactive renal tubular cells and low grade urothelial carcinoma cells? Cytopathology 2010 Jan 22. DOI: 10.1111/j.1365-2303.2009.00729.x [Epub ahead of print].
6. Ohsaki H, Hirakawa E, Kagawa K et al. Value of computer-assisted quantitative nuclear morphometry for differentiation of reactive renal tubular cells from low-grade urothelial carcinoma. Cytopathology 2010 Jan 22. DOI: 10.1111/j.1365-2303.2009.00731.x [Epub ahead of print].
7. Grone HJ, Weber K, Grone E et al. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol 1987;129:1-8.
8. Hertig A, Anglicheau D, Verine J et al. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 2008;19:1584-91.
9. Southgate J, Harnden P, Trejdosiewicz LK. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol 1999;14:657-64.
10. Varma M, Morgan M, Amin MB et al. High molecular weight cytokeratin antibody (clone 34ßE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology 2003;42:167-72.
11. Ramos D, Navarro S, Villamón R et al. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder. Cancer 2003;97:1876-83.
12. McKee G. Urinary tract cytology. In: Diagnostic Cytopathology, 2nd edn. Gray W, McKee G (eds). Edinburgh: Churchill Livingstone; 2003: pp. 471-97.
13. Takahashi M. Urinary Tract. In: Color Atlas of Cancer Cytology, 3rd edn. Takahashi M (ed.). Tokyo: Igaku-Shoin; 2000: pp. 326-64.
14. Murata S, Kishikawa T, Isojima Y et al. Unusual cytologic findings in low grade papillary transitional cell carcinoma. Acta Cytol 2004;48:492-6.
15. Ohsaki H, Nakamura M, Nagamachi K, Ogino T. Study on sample preparation for urine cytology. J Jpn Soc Clin Cytol 2005;44:215-8 (in Japanese with an English abstract).
16. Parker DC, Folpe AL, Bell J et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 2003;27:1-10.
17. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
18. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008;99:1375-9.
19. Zeisberg EM, Potenta SE, Sugimoto H et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008;19:2282-7.
20. Zeisberg M, Yang C, Martino M et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-47.
21. Kim KK, Kugler MC, Wolters PJ et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-5.
22. Okada H, Strutz F, Danoff TM, Kalluri R, Neilson EG. Possible mechanisms of renal fibrosis. Contrib Nephrol 1996;118:147-54.